Information
-
Trademark
-
98309999
-
International Classifications
-
Filing Date
December 12, 2023
11 months ago
-
Transaction Date
November 05, 2024
21 days ago
-
Status Date
November 05, 2024
21 days ago
-
Published for Opposition Date
November 05, 2024
21 days ago
-
Location Date
September 30, 2024
a month ago
-
Status Code
686
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
SANDER, DREW
-
Attorney Docket Number
1958427.411
Attorney Name
Alexis Crawford Douglas
Law Office Assigned Location Code
O40
-
Owners
Mark Drawing Code
4
Mark Identification
DRAW-TO-THAW
Case File Statements
- GS0401: Cryopreservation of human cells
- GS0391: Storage of blood and stem cells for medical use; human stem cell storage for medical use
- GS0051: Products to support and manage transfusion medicine and regenerative medicine from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products, namely cord blood, leukopaks, buffy coats for medical use, antibody positive blood plasma, blood components for medical purposes, namely, phenotyped red cell units and monoclonal antibodies, cord blood all for use in medical diagnoses and treatment; mononuclear cells for medical use, progenitor cells for medical use, antibody preparations for medical use in medical clinical trials and medical purposes
- GS0351: Providing independent review of clinical trials for business purposes
- GS0011: Products to support and manage cellular therapy related research and clinical programs from discovery through development and to the clinic, namely, blood plasma, blood for medical purposes, blood products, namely cord blood, leukopaks, buffy coats for clinical trial use, antibody positive blood plasma, blood components for medical purposes, namely, phenotyped red cell units and monoclonal antibodies, cord blood all for use in medical and clinical research
- GS0441: Blood bank services; tissue bank services; collection and preservation of human blood, red blood cells, plasma and bone marrow; apheresis, namely, removal, treatment, and processing of human blood; T cell isolation services, namely, medical services involving the removal, treatment, and processing of human blood to isolate t cells
- GS0421: Pharmaceutical research services and conducting pharmaceutical clinical trials for others; medical research laboratory services, namely, cell processing services for use by others
Case File Event Statements
-
12/12/2023 - 11 months ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
3/14/2024 - 8 months ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
7/11/2024 - 4 months ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
7/19/2024 - 4 months ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
7/19/2024 - 4 months ago
6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
7/19/2024 - 4 months ago
5 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
7/19/2024 - 4 months ago
4 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
8/6/2024 - 3 months ago
9 - WITHDRAWN FROM PUB - OG REVIEW QUERY
Type: PBCR
-
9/12/2024 - 2 months ago
15 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
9/12/2024 - 2 months ago
10 - PREVIOUS ALLOWANCE COUNT WITHDRAWN
Type: ZZZX
-
9/12/2024 - 2 months ago
13 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
9/12/2024 - 2 months ago
12 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
7/19/2024 - 4 months ago
7 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
9/12/2024 - 2 months ago
11 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
9/12/2024 - 2 months ago
14 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
10/16/2024 - a month ago
16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
11/5/2024 - 21 days ago
17 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
11/5/2024 - 21 days ago
18 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB